NASDAQ:FMED

Fidelity Disruptive Medicine ETF (FMED) Price, Holdings, & News

$25.90 +0.15 (+0.56%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Fidelity Disruptive Medicine ETF (NASDAQ:FMED)

Key Stats

Today's Range
$25.60
$25.92
50-Day Range
$24.66
$26.61
52-Week Range
$23.32
$26.79
Volume
6,558 shs
Average Volume
5,851 shs
Market Capitalization
$54.32 million
Assets Under Management
$55.35 million
Dividend Yield
0.43%
Net Expense Ratio
0.50%
Aggregate Rating
Moderate Buy

ETF Overview

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.

Fidelity Disruptive Medicine ETF Expenses

TypeFMEDTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.57%0.55%0.51%0.52%
Other Expenses0.00%0.57%0.50%0.46%0.53%
Total Expense0.50%0.72%0.72%0.66%0.71%
Fee Waiver0.00%-0.72%-0.50%-0.31%-0.56%
Net Expense0.50%0.60%0.62%0.60%0.60%
Receive FMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fidelity Disruptive Medicine ETF and its competitors with MarketBeat's FREE daily newsletter.

FMED ETF News Headlines

Fidelity Disruptive Medicine ETF declares $0.112 dividend
See More Headlines

FMED ETF - Frequently Asked Questions

Fidelity Disruptive Medicine ETF's stock was trading at $24.66 at the start of the year. Since then, FMED shares have increased by 4.9% and is now trading at $25.8650.
View the best growth stocks for 2025 here
.

Shares of FMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Fund Details

Issuer
Fidelity
Fund Name
Fidelity Disruptive Medicine ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:FMED
Inception Date
6/12/2023
Fund Manager
Niamh Brodie-Machura, Camille Carlstrom, Tim Codrington,Charlie Hebard,Michael Kim, Christopher Lee,William Shanley
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
62

Fund Statistics

Assets Under Management
$55.35 million
Average Daily Volume
$0.00
Discount/Premium
-0.03%

Administrator, Advisor and Custodian

Administrator
Fidelity Management & Research Company LLC
Advisor
Fidelity Management & Research Company LLC
Custodian
State Street Bank and Trust Company
Distributor
Fidelity Distributors Company LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
9,100 shs

Miscellaneous

Beta
0.94
Creation Fee
$200.00
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Top 10 FMED Holdings

FMED Sector Exposure

FMED Industry Exposure


This page (NASDAQ:FMED) was last updated on 2/12/2025 by MarketBeat.com Staff
From Our Partners